Please find enclosed herewith Performance Update for the Quarter and Financial Year ended March 31, 2026.

Pat Growth 25pctRevenue Growth 20pctEbitda Margin ExpansionResults View source PDF Explain this filing

GODREJIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.3%Reaction day

₹1130.00

prior close

₹1130.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.2%+2.5% vs market

Diversified peers, median of 12sector-2.6%+4.9% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Midcap 150 and 4.9 pts more than its Diversified peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.6

10m

+4.0

15m

+5.8

30m

+1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.3-0.2+2.5-2.6+4.9

Next day

-0.5+0.5-1.1-1.9+1.4

-0.8+0.9-1.7-2.0+1.2

-1.3+1.0-2.3-1.8+0.4

-0.7+1.1-1.8-1.4+0.7

+3.2+2.0+1.2-1.5+4.7

+0.8+2.8-2.0-0.6+1.4

15d

-7.3-0.2-7.2-3.8-3.5

-1.4+2.9-4.3-1.1-0.3

+21.0+3.7+17.3-2.8+23.7

+8.4+5.0+3.4-3.6+12.0

UpDownMarket · Nifty Midcap 150Sector · Diversified peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Godrej Industries reported strong consolidated results for FY26 with total income of ₹25,981 crore, up 19% year-on-year. Net profit grew 26% to ₹1,241 crore, while PBDIT increased 34% to ₹6,365 crore. Q4 performance was particularly robust with net profit surging 143% to ₹444 crore on the back of 29% revenue growth. The Chemicals segment delivered 22% revenue growth, while subsidiary Godrej Properties reported booking value of ₹34,171 crore, up 16% YoY. Godrej Agrovet showed strong volume growth of 15% in Animal Nutrition with margin expansion. Overall, the consolidated performance reflects broad-based growth across all major business segments including FMCG, real estate, chemicals, and agri-business.

Likely market impact

Strong bottom-line growth with 26% PAT increase and 34% EBITDA growth signals operational efficiency gains. The stock appears well-positioned given robust performance across subsidiaries, though high comparison bases in Q4 may limit further upside momentum.